s discretion.

4 trials

Sponsors

Teikyo University Hospital, University of British Columbia, Osaka General Medical Center, Other

Conditions

Bipolar DisorderCoronary Artery DiseaseCoronary artery disease

Phase 3

A 6-Week Randomised, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Patients (ELICE-BD)

RecruitingJPRN-UMIN000025167

University of British ColumbiaBipolar Disorder

Start: 2018-03-31Target: 150Updated: 2026-06-29

Unknown Phase

3-Month Discontinuation of Dual Antiplatelet Therapy after Ultimaster Sirolimus-Eluting Stent Implantation

Active, not recruitingJPRN-UMIN000022695

Teikyo University HospitalCoronary Artery Disease

Start: 2016-09-27Target: 1500Updated: 2026-06-29

The degree of endothelial dysfunction caused by treatment of de novo coronary lesion with drug-coated balloon as compared to drug-eluting stent

Active, not recruitingJPRN-UMIN000032152

Osaka General Medical CenterCoronary artery disease

Start: 2018-04-09Target: 50Updated: 2026-06-29

A prospective, open-label, single-centre, randomized study to evaluate coronary microcirculation in de-novo lesions treated with drug-coated balloons or drug-eluting stents

RecruitingJPRN-UMIN000052443

OtherCoronary artery disease

Start: 2023-10-09Target: 50Updated: 2026-06-29